These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19169493)

  • 41. Comparison of diabetes phenotype in children and their mothers with permanent neonatal diabetes mellitus carrying the same
    Stanik J; Barak L; Dankovcikova A; Valkovicova T; Skopkova M; Gasperikova D
    Endocr Regul; 2020 Nov; 54(4):260-265. PubMed ID: 33885251
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
    Lauridsen MH; Boesgaard TW; Pedersen OB; Hansen T; Hertz B
    Ugeskr Laeger; 2009 Jun; 171(23):1923-4. PubMed ID: 19500515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2.
    Bahi-Buisson N; Eisermann M; Nivot S; Bellanné-Chantelot C; Dulac O; Bach N; Plouin P; Chiron C; de Lonlay P
    J Child Neurol; 2007 Sep; 22(9):1147-50. PubMed ID: 17890419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.
    Sastre J; Luque A; del Val F; Aragonés A; López J
    Diabetes Care; 2014; 37(3):e55-6. PubMed ID: 24558086
    [No Abstract]   [Full Text] [Related]  

  • 45. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child.
    Yang W; Wei H; Sang Y
    J Pediatr Endocrinol Metab; 2013; 26(5-6):591-4. PubMed ID: 23640936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy.
    Shah B; Breidbart E; Pawelczak M; Lam L; Kessler M; Franklin B
    J Pediatr Endocrinol Metab; 2012; 25(3-4):353-6. PubMed ID: 22768668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.
    Flanagan SE; Edghill EL; Gloyn AL; Ellard S; Hattersley AT
    Diabetologia; 2006 Jun; 49(6):1190-7. PubMed ID: 16609879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neonatal Diabetes: Two Cases with Isolated Pancreas Agenesis due to Homozygous PTF1A Enhancer Mutations and One with Developmental Delay, Epilepsy, and Neonatal Diabetes Syndrome due to KCNJ11 Mutation.
    Evliyaoğlu O; Ercan O; Ataoğlu E; Zübarioğlu Ü; Özcabı B; Dağdeviren A; Erdoğan H; De Franco E; Ellard S
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):168-174. PubMed ID: 28943513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene.
    Joshi R; Phatarpekar A
    World J Pediatr; 2011 Nov; 7(4):371-2. PubMed ID: 21210267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up.
    Ješić MD; Stock H; Zdravković V; Kovačević S; Savić M; Ješić MM
    Turk J Pediatr; 2021; 63(3):490-494. PubMed ID: 34254494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O; Iafusco D; D'Amato E; Gloyn AL; Hattersley AT; Pasquino B; Tonini G; Dammacco F; Zanette G; Meschi F; Porzio O; Bottazzo G; Crinó A; Lorini R; Cerutti F; Vanelli M; Barbetti F;
    Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
    Kylat RI; Senguttuvan R; Bader MY
    J Pediatr Endocrinol Metab; 2017 May; 30(5):593-596. PubMed ID: 28350539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation.
    Iafusco D; Zanfardino A; Piscopo A; Casaburo F; De Nigris A; Alfiero S; Russo G; Arenella M; Russo MC; Barbetti F
    Diabetologia; 2021 Jul; 64(7):1703-1706. PubMed ID: 33987715
    [No Abstract]   [Full Text] [Related]  

  • 54. Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.
    Slingerland AS; Hurkx W; Noordam K; Flanagan SE; Jukema JW; Meiners LC; Bruining GJ; Hattersley AT; Hadders-Algra M
    Diabet Med; 2008 Mar; 25(3):277-81. PubMed ID: 18307455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.
    Tonini G; Bizzarri C; Bonfanti R; Vanelli M; Cerutti F; Faleschini E; Meschi F; Prisco F; Ciacco E; Cappa M; Torelli C; Cauvin V; Tumini S; Iafusco D; Barbetti F;
    Diabetologia; 2006 Sep; 49(9):2210-3. PubMed ID: 16816952
    [No Abstract]   [Full Text] [Related]  

  • 56. A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.
    Tammaro P; Flanagan SE; Zadek B; Srinivasan S; Woodhead H; Hameed S; Klimes I; Hattersley AT; Ellard S; Ashcroft FM
    Diabetologia; 2008 May; 51(5):802-10. PubMed ID: 18335204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Permanent Neonatal Diabetes (DEND Syndrome).
    Khan SA; Parkash A; Ibrahim M
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):114-115. PubMed ID: 28666500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.
    Abbasi F; Saba S; Ebrahim-Habibi A; Sayahpour FA; Amiri P; Larijani B; Amoli MM
    Mol Diagn Ther; 2012 Apr; 16(2):109-14. PubMed ID: 22471336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early Postnatal Use of Glibenclamide in Permanent Neonatal Diabetes Secondary to Antenatally Diagnosed KJCN11 Mutation.
    Walton-Betancourth S; Ashford J; Beardsall K; Gooding N; Gurnell EM; Hendriks E; Hysted H; Lee J; Thankamony A; Tseretopoulou X; Win M; Williams RM
    Horm Res Paediatr; 2022; 95(5):476-483. PubMed ID: 35817008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal diabetes mellitus: a disease linked to multiple mechanisms.
    Polak M; Cavé H
    Orphanet J Rare Dis; 2007 Mar; 2():12. PubMed ID: 17349054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.